Abstract
BackgroundThe prognosis for patients with hepatocellular carcinoma (HCC) is poor, and the mechanisms underlying the development of HCC remain unclear. Notch1 and Notch3 may be involved in malignant transformation, although their roles remain unknown.Materials and MethodsHCC tissues were stained with anti-Notch1 or -Notch3 antibody. The migration and invasion capacities of the cells were measured with transwell cell culture chambers. RT-PCR was used to measure the expression of Notch1 and Notch3 mRNA. Additionally, western blot analysis was used to assess the protein expression of Notch1, Notch3, CD44v6, E-cadherin, matrix metalloproteinase-2 (MMP-2), MMP-9, and urokinase-type plasminogen activator (uPA). RNA interference was used to down-regulate the expression of Notch1 and Notch3. Cell viability was assessed using MTT.ResultsBased on immunohistochemistry, high Notch1 expression was correlated with tumor size, tumor grade, metastasis, venous invasion and AJCC TNM stage. High Notch3 expression was only strongly correlated with metastasis, venous invasion and satellite lesions. Kaplan-Meier curves demonstrated that patients with high Notch1 or Notch3 expression were at a significantly increased risk for shortened survival time. In vitro, the down-regulation of Notch1 decreased the migration and invasion capacities of HCC cells by regulating CD44v6, E-cadherin, MMP-2, MMP-9, and uPA via the COX-2 and ERK1/2 pathways. Down-regulation of Notch3 only decreased the invasion capacity of HCC cells by regulating MMP-2 and MMP-9 via the ERK1/2 pathway.ConclusionsBased on the migration and invasion of HCC, we hypothesize that targeting Notch1 may be more useful than Notch3 for designing novel preventive and therapeutic strategies for HCC in the near future.
Highlights
Systemic chemotherapy is ineffective in hepatocellular carcinoma (HCC), as evidenced by low response rates and no demonstrated survival benefit
Based on immunohistochemistry, high Notch1 expression was correlated with tumor size, tumor grade, metastasis, venous invasion and AJCC TNM stage
Weak positive staining of Notch1 was detected in 31 samples of HCC, moderate positive staining was detected in 17 samples, and strong positive staining was detected in 29 samples
Summary
Systemic chemotherapy is ineffective in hepatocellular carcinoma (HCC), as evidenced by low response rates and no demonstrated survival benefit. Liver transplantation is considered the only curative treatment option for HCC. Its use has been restricted by factors such as the scarcity of donor organs and the risks associated with primary hepatic resection. Many patients undergo different therapies, yet the prognosis of HCC remains dismal, which is mainly attributed to the aggressive metastasis and recurrence of HCC [1]. The mechanisms underlying the development of HCC remain unclear. Most studies have focused on Notch and Notch, which may be involved in malignant transformation. The prognosis for patients with hepatocellular carcinoma (HCC) is poor, and the mechanisms underlying the development of HCC remain unclear. Notch and Notch may be involved in malignant transformation, their roles remain unknown
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have